Cargando…
Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
The biologic era has greatly improved the treatment of Crohn’s disease and ulcerative colitis. Biologics can however induce a wide variety of skin eruptions, especially those targeting the TNF-α and Th17 pathway. These include infusion reactions, eczema, psoriasis, lupus, alopecia areata, vitiligo,...
Autores principales: | Lambert, Jo L. W., De Schepper, Sofie, Speeckaert, Reinhart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959457/ https://www.ncbi.nlm.nih.gov/pubmed/33802483 http://dx.doi.org/10.3390/jcm10051040 |
Ejemplares similares
-
JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
por: Alves de Medeiros, Ana Karina, et al.
Publicado: (2016) -
Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
por: Speeckaert, Reinhart, et al.
Publicado: (2021) -
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021) -
Cutaneous manifestations in inflammatory bowel disease (Review)
por: Ungureanu, Loredana, et al.
Publicado: (2020) -
Learning From Success and Failure: Biologics for Non-approved Skin Diseases
por: Speeckaert, Reinhart, et al.
Publicado: (2019)